---
document_datetime: 2024-11-27 12:02:36
document_pages: 23
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/onbrez-breezhaler-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
document_name: onbrez-breezhaler-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
version: success
processing_time: 37.2640824
conversion_datetime: 2025-12-19 03:39:23.864947
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
## Onbrez Breezhaler

Proceduralstepstakenandscientificinformationaftertheauthorisation

| Application number   | Scope                                                                                                                                                                                                                     | Opinion/ Notification 1 issued on   | Commission Decision Issued2 / amended on   | Product Information affected3   | Summary   |
|----------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------|--------------------------------------------|---------------------------------|-----------|
| IG/1807              | B.11.b.2.c.1-Change to importer,batch release arrangements and quality control testing of the FP - Replacementoradditionofamanufacturer responsibleforimportation and/orbatchrelease- Not including batch control/testing | 21/11/2024                          |                                            | Annex II and PL                 |           |

1 Notifications are issued for type I variations and Article 61(3) notifications (unless part of a group including a type II variation or extension application or a worksharing application). Opinions areissuedfor all otherprocedures.

3 SmPC (Summary of Product Characteristics), Annex II, Labelling, PL (Package Leaflet).

2 A Commission decision(CD) is issued for procedures that affect the terms of the marketing authorisation (e.g. summary of product characteristics, annex II, labelling, package leaflet).The CD is issued within two months of the opinionfor variations falling under the scope of Article 23.1a(a)of Regulation(Eu)No.712/2012, or within oneyear for other procedures.

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

| IG/1757            | A.7-Administrativechange-Deletionof manufacturing sites                                                                                                                                                                                                                                                                                                                                                                                                                                  | 14/06/2024   | n/a   |                                |
|--------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|-------|--------------------------------|
| IG/1731            | B.II.b.1.a-Replacement or addition of a manufacturing site for the Fp - Secondary packaging site                                                                                                                                                                                                                                                                                                                                                                                         | 19/03/2024   | n/a   |                                |
| IG/1664/G          | This was an application for a group of variations. A.4-Administrative change-Change in the name and/oraddressofamanufactureroranASMFholder orsupplieroftheAS，startingmaterial,reagentor intermediateused in themanufacture of theASor manufacturer of a novel excipient A.4-Administrative change-Change in the name and/oraddressofamanufactureror anASMFholder orsupplieroftheAS，startingmaterial,reagentor intermediateused in themanufactureof theASor manufacturerofanovelexcipient | 29/09/2023   | n/a   |                                |
| IB/0067/G          | This was an applicationfor a group of variations. B.I.a.2.a-Changes in the manufacturing process of theAS-Minor changein themanufacturingprocess oftheAS B.I.a.2.a-Changes in the manufacturingprocess of theAS-Minor change in the manufacturingprocess of the AS                                                                                                                                                                                                                       | 22/08/2023   | n/a   |                                |
| PSUSA/1730/ 202211 | PeriodicSafetyUpdateEUSingleassessment- indacaterol                                                                                                                                                                                                                                                                                                                                                                                                                                      | 06/07/2023   | n/a   | PRACRecommendation-maintenance |

<div style=\"page-break-after: always\"></div>

| This was an applicationfor a group ofvariations.                                                                                                                                                                                                                                                                                                 | 12/04/2023   | n/a        |                 | IG/1605/G   |
|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|-----------------|-------------|
| B.II.e.7.b - Change in supplier of packaging components or devices (when mentioned in the dossier)-Replacementoradditionofasupplier                                                                                                                                                                                                              | 17/05/2022   | n/a        |                 | IG/1513     |
| B.II.e.6.b - Change in any part of the (primary) packagingmaterial notincontactwith thefinished product formulation - Change that does not affect theproductinformation                                                                                                                                                                          | 22/11/2021   | n/a        |                 | IG/1452     |
| A.4-Administrative change-Change in thename and/oraddressof amanufactureroranASMFholder orsupplieroftheAS，startingmaterial,reagentor intermediateusedinthemanufactureof theASor manufacturerofanovelexcipient                                                                                                                                    | 10/08/2021   | n/a        |                 | IG/1428     |
| This was an applicationfor a group of variations. A.5.b-Administrative change-Change in the name and/or address of a manufacturer/importer of the finished product, including quality control sites (excludingmanufacturerforbatchrelease) B.II.b.2.c.1 - Change to importer, batch release arrangements and quality control testing of the FP - | 06/08/2021   | 13/12/2021 | Annex II and PL | IG/1424/G   |

<div style=\"page-break-after: always\"></div>

| Replacementoradditionofamanufacturer responsible for importation and/or batch release - Notincludingbatchcontrol/testing                                                                                                                                                                                                                                                                                                                             |            |            |                                  |           |
|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----------------------------------|-----------|
| B.II.e.7.a - Change in supplier of packaging components or devices (when mentioned in the dossier) - Deletion of a supplier                                                                                                                                                                                                                                                                                                                          | 12/02/2021 | n/a        |                                  | IG/1357   |
| A.4-Administrative change -Change in the name and/oraddressofamanufactureroranASMFholder orsupplieroftheAS，startingmaterial,reagentor intermediateusedinthemanufactureoftheASor manufacturerofanovelexcipient                                                                                                                                                                                                                                        | 08/01/2021 | n/a        |                                  | IG/1309   |
| This was an application for a variation following a worksharing procedure according to Article 20 of CommissionRegulation(EC)No1234/2008. C.I.z-Changes(Safety/Efficacy)of Human and VeterinaryMedicinalProducts-Othervariation                                                                                                                                                                                                                      | 10/12/2020 | 13/12/2021 | SmPC, Annex I1, Labelling and PL | WS/1931   |
| Thiswasanapplicationforagroupofvariations. B.II.c.3.z-Change in source of an excipient or reagent with TSE risk - Other variation B.IIl.1.b.2-Submission of a new/updated or deletion of Ph. Eur. TSE Certificate of Suitability - New certificate for a starting material/reagent/intermediate/orexcipientfroma new or an already approved manufacturer B.II1.1.b.2-Submission of a new/updated or deletion ofPh.Eur.TSE Certificate ofSuitability- | 21/07/2020 | n/a        |                                  | IG/1271/G |

<div style=\"page-break-after: always\"></div>

<!-- image -->

|                    | New certificate for a starting material/reagent/intermediate/orexcipientfroma new or an already approved manufacturer B.III.1.b.2-Submission of a new/updated or deletion of Ph. Eur. TSE Certificate of Suitability - New certificate for a starting material/reagent/intermediate/orexcipientfroma new or an already approved manufacturer B.IIl.1.b.2-Submission of a new/updated or deletion ofPh.Eur.TSE Certificate of Suitability- New certificate for a starting material/reagent/intermediate/orexcipientfroma neworanalreadyapprovedmanufacturer B.III.1.b.2-Submission of a new/updated or deletion of Ph. Eur. TSE Certificate of Suitability - New certificate for a starting material/reagent/intermediate/orexcipientfroma new or an already approved manufacturer B.III.1.b.3-Submission of a new/updated or deletion ofPh.Eur.TSE Certificate of Suitability- Updatedcertificatefromanalreadyapproved manufacturer B.II1.1.b.4-Submission of a new/updated or deletion ofPh.Eur.TSE Certificate ofSuitability- Deletion of certificates(in casemultiple certificates   |            |     |
|--------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|
| PSUSA/1730/ 201911 | PeriodicSafetyUpdateEUSingle assessment- indacaterol                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    | 09/07/2020 | n/a |
| IG/1229            | A.7-Administrativechange-Deletion of manufacturing sites                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                | 13/03/2020 | n/a |

<div style=\"page-break-after: always\"></div>

| IG/1192/G   | This was an application for a group of variations. A.7-Administrativechange-Deletionof manufacturing sites B.11.b.2.c.1-Change to importer,batch release arrangements and quality control testing of the FP - Replacementoradditionofamanufacturer responsible for importation and/or batch release - Notincludingbatchcontrol/testing   | 28/01/2020   | 09/12/2020   | Annex II and PL        |                              |
|-------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|--------------|------------------------|------------------------------|
| WS/1708     | This was an application for a variation following a worksharingprocedureaccordingtoArticle20of CommissionRegulation(EC)No1234/2008. C.I.z - Changes (Safety/Efficacy) of Human and VeterinaryMedicinalProducts-Othervariation                                                                                                            | 12/12/2019   | 09/12/2020   | SmPC, Labelling and PL |                              |
|             | Thiswas an applicationfor a group of variations. A.7-Administrative change-Deletion of manufacturing sites A.7-Administrativechange-Deletionof                                                                                                                                                                                           | 12/03/2019   | n/a          |                        | IG/1073/G manufacturingsites |
|             | Thiswas an applicationfor a group of variations. B.II.b.1.e - Replacement or addition of a manufacturing site for the FP - Site where any manufacturing operation(s) take place, except batch- release, batch control, primary and secondary packaging, for non-sterile medicinal products                                               | 16/11/2018   | n/a          |                        | IB/0051/G                    |

<div style=\"page-break-after: always\"></div>

<!-- image -->

|           | B.II.b.2.a-Change to importer,batch release arrangements and quality control testing of the FP - Replacement/additionofasitewherebatch control/testingtakesplace B.II.b.3.a - Change in the manufacturing process of the finished or intermediate product - Minor change in themanufacturingprocess                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |            |     |
|-----------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|
| WS/1440/G | Thiswas anapplicationfor agroupofvariations following a worksharing procedure according to Article 20 of Commission Regulation (EC) No 1234/2008. B.I.b.1.b-Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent-Tightening of specification limits B.I.b.1.b-Change in the specificationparameters and/or limits of an AS, starting material/intermediate/reagent-Tighteningof specification limits B.I.b.1.c-Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent-Additionofanew specification parameter to the specification with its corresponding test method B.I.b.2.a-Change in testprocedure forAS or startingmaterial/reagent/intermediate-Minor changes to an approved test procedure B.I.b.1.b -Change in the specification parameters and/or limits of an AS, starting | 13/09/2018 | n/a |

<div style=\"page-break-after: always\"></div>

|           |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |            |            |                                  | specification limits   |
|-----------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----------------------------------|------------------------|
| IA/0050   | C.I.z-Changes(Safety/Efficacy)of Human and VeterinaryMedicinalProducts-Othervariation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           | 23/08/2018 | 26/08/2019 | SmPC, Annex I1, Labelling and PL |                        |
| IB/0049/G | Thiswasanapplicationfor agroupofvariations. B.II.a.3.b.6-Changesinthecomposition (excipients) of the finished product - Other excipients -Replacementofa single excipientwith a comparableexcipientwiththe samefunctional characteristicsand atasimilarlevel B.II.d.2.a - Change in test procedure for the finished product-Minorchangestoanapprovedtest procedure B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure B.II.d.2.a-Change in test procedure for the finished product - Minor changes to an approved test procedure B.II.d.2.a-Change in test procedure for the finished product - Minor changes to an approved test procedure B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure | 24/07/2018 | n/a        |                                  |                        |

<div style=\"page-break-after: always\"></div>

|           | product-Minor changesto an approved test                                                                                                                                                                                                                                                                                                                           |            |            |                        | procedure                   |
|-----------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|-----------------------------|
| IG/0950   | A.5.b-Administrative change-Change in the name and/or address of a manufacturer/importer of the finished product, including quality control sites (excludingmanufacturerforbatchrelease)                                                                                                                                                                           | 18/06/2018 | n/a        |                        |                             |
|           | This was an applicationfor a group of variations. B.III.1.b.3-Submission of a new/updated or deletion of Ph. Eur. TSE Certificate of Suitability - Updatedcertificatefrom an alreadyapproved manufacturer B.III.1.b.4-Submission of a new/updated or deletion of Ph. Eur. TSE Certificate of Suitability - Deletion of certificates (in case multiple certificates | 26/04/2018 | n/a        |                        | IG/0927/G existpermaterial) |
|           | TransferofMarketingAuthorisation                                                                                                                                                                                                                                                                                                                                   | 26/03/2018 | 23/04/2018 | SmPC, Labelling and PL | T/0045                      |
| WS/1254/G | Thiswas an applicationfor a groupof variations following a worksharing procedure according to Article 20 of Commission Regulation(EC) No 1234/2008. A.7-Administrative change-Deletion of manufacturing sites B.I.a.1.a-Change in the manufacturer of AS or of a startingmaterial/reagent/intermediateforAs-The                                                    | 14/12/2017 | n/a        |                        |                             |

<div style=\"page-break-after: always\"></div>

|                    | proposed manufacturer is part of the same pharmaceuticalgroupasthecurrentlyapproved manufacturer B.I.a.1.g-Change in the manufacturerofASor ofa starting material/reagent/intermediate for AS - Introduction of a new manufacturer of the AS that is notsupportedby anASMFandrequiressignificant updateto therelevantASsectioninthedossier                                                                                                                  |            |            |           |                                                                                                                              |
|--------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-----------|------------------------------------------------------------------------------------------------------------------------------|
| IG/0879            | A.7-Administrativechange-Deletion of manufacturing sites                                                                                                                                                                                                                                                                                                                                                                                                    | 11/12/2017 | n/a        |           |                                                                                                                              |
| N/0043             | Minor change in labelling or package leaflet not connected with theSPC(Art.61.3 Notification)                                                                                                                                                                                                                                                                                                                                                               | 06/11/2017 | 23/04/2018 | Labelling |                                                                                                                              |
| PSUSA/1730/ 201611 | Periodic Safety Update EU Single assessment - indacaterol                                                                                                                                                                                                                                                                                                                                                                                                   | 20/07/2017 | 26/09/2017 | Annex II  | RefertoScientificconclusionsandgroundsrecommending thevariationto termsoftheMarketingAuthorisation(s)'for PSUSA/1730/201611. |
| IG/0784/G          | Thiswas anapplicationfor agroupofvariations. B.II.c.1.a-Change in the specification parameters and/or limits of an excipient -Tightening of specification limits B.II.c.1.a-Change in the specification parameters and/or limits of an excipient -Tightening of specification limits B.II.c.1.a-Change in the specification parameters and/or limits of an excipient - Tightening of specification limits B.II.c.1.b-Change in the specification parameters | 31/03/2017 | n/a        |           |                                                                                                                              |

<div style=\"page-break-after: always\"></div>

| specification parameter to the specification with its corresponding test method B.II.c.2.a-Change in test procedure for an excipient - Minor changes to an approved test procedure B.II.c.2.a-Change in test procedure for an excipient - Minor changes to an approved test procedure B.III.2.z-Change to comply withPh.Eur.orwith a nationalpharmacopoeiaofaMemberState-Other variation   |            |            |      |         |
|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------|---------|
| This was an application for a variation following a worksharing procedure according to Article 20 of CommissionRegulation(EC)No1234/2008. B.II.f.1.b.1 - Stability of FP - Extension of the shelf lifeof thefinishedproduct-Aspackagedforsale (supported byreal time data)                                                                                                                 | 23/02/2017 | 26/09/2017 | SmPC | WS/1102 |
| A.5.b - Administrative change - Change in the name and/oraddressofamanufacturer/importerofthe finished product, including quality control sites (excluding manufacturer forbatchrelease)                                                                                                                                                                                                   | 03/08/2016 | n/a        |      | IG/0712 |
| Thiswas an applicationfor avariationfollowing a worksharingprocedureaccordingtoArticle20of CommissionRegulation(EC)No1234/2008. The MAH submitted the final study report of US PASS update to fulfil MEA017/MEA015/MEA015 for Onbrez Breezhaler(EMEA/H/C/1114)and duplicate authorizationsHirobrizBreezhaler(EMEA/H/C/1211)                                                                | 23/06/2016 | n/a        |      | WS/0944 |

<div style=\"page-break-after: always\"></div>

<!-- image -->

|           | and Oslif Breezhaler (EMEA/H/C/1210). The revisions of the RMP were also accepted (version 9.0) reflecting the results from this study and its completion. C.I.13 - Other variations not specifically covered elsewhereinthisAnnexwhichinvolvethesubmission of studies to the competent authority                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |            |     |                                                    |
|-----------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|----------------------------------------------------|
| WS/0777/G | Thiswas an applicationfor a groupofvariations following a worksharing procedure according to Article20ofCommissionRegulation(EC)No 1234/2008. Submissionof thefinal studyreportsof 2PASS studies (UK PASS study QAB149B2431/QAB149AS232863)includedinthe RMPtomonitoroff-label useofindacaterol inasthma patients and to monitor specified safety risks among initiatorsofindacaterolrelativetoinitiatorsofother long-acting beta2-agonists (LABA) medications for the COPD indication; an updated RMP(version 8.1) hasbeensubmitted.Additionally,theMAH tookthe opportunity to amend the RMP in line with the conclusions of previous assessment of RMP measures. C.I.13 - Other variations not specifically covered elsewhereinthisAnnexwhichinvolvethesubmission ofstudiestothecompetentauthority | 23/07/2015 | n/a | C.I.13 - Other variations not specifically covered |

<div style=\"page-break-after: always\"></div>

|           | elsewherein thisAnnexwhich involve thesubmission of studies to the competent authority C.1.11.z - Introduction of, or change(s) to, the obligations and conditions of a marketing authorisation，includingtheRMP-Othervariation                                                                                                 |            |            |                        |                                                                                                                                                                                                                                                                            |
|-----------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IB/0034/G | Thiswas an applicationfor a group of variations. C.I.11.z-Introduction of, or change(s) to, the obligations and conditions of a marketing authorisation,including theRMP-Othervariation C.1.11.z-Introduction of, or change(s) to, the obligations and conditions of a marketing authorisation,including theRMP-Othervariation | 10/02/2015 | n/a        |                        |                                                                                                                                                                                                                                                                            |
| IG/0484/G | This was an application for a group of variations. A.7-Administrativechange-Deletion of manufacturing sites B.II.b.1.a-Replacement or addition of a manufacturing site for the FP - Secondary packaging site                                                                                                                   | 12/11/2014 | n/a        |                        |                                                                                                                                                                                                                                                                            |
| IG/0488   | A.1-Administrativechange-Changeinthename and/oraddressoftheMAH                                                                                                                                                                                                                                                                 | 13/10/2014 | 15/10/2015 | SmPC, Labelling and PL |                                                                                                                                                                                                                                                                            |
| R/0029    | Renewalof themarketing authorisation.                                                                                                                                                                                                                                                                                          | 24/07/2014 | 18/09/2014 | SmPC, Labelling and PL | Based on the review of data on quality, safety and efficacy theCHMPconsideredthattherisk-benefitbalanceofthe product in the maintenance bronchodilator treatment of airflow obstruction in adult patients withCOPDremains favourableandthereforerecommendedtherenewalofthe |

<div style=\"page-break-after: always\"></div>

|           |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |            |     | marketing authorisation.The CHMPrecommended that the renewal be granted with unlimited validity.   |
|-----------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|----------------------------------------------------------------------------------------------------|
| IB/0031   | C.1.11.z-Introduction of, or change(s) to, the obligations and conditions of a marketing authorisation,including the RMP-Othervariation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   | 29/07/2014 | n/a |                                                                                                    |
| PSUV/0030 | Periodic Safety Update                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    | 13/06/2014 | n/a | PRACRecommendation-maintenance                                                                     |
| IB/0028   | B.II.b.3.z-Change in the manufacturing process of thefinished orintermediateproduct-Othervariation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        | 12/03/2014 | n/a |                                                                                                    |
| IG/0389/G | This was an applicationfor a group ofvariations. B.II.a.1.a - Change or addition of imprints, bossing or other markingsincludingreplacement, or addition of inks used for product marking - Changes in imprints, bossing or other markings B.II.b.1.b-Replacement or addition of a manufacturing site for the FP - Primary packaging site B.II.b.2.a-Change to importer,batch release arrangements and quality control testing of the FP - Replacement/additionofasitewherebatch control/testingtakesplace A.7-Administrativechange-Deletionof manufacturing sites A.7-Administrativechange-Deletion of manufacturing sites A.5.b-Administrativechange-Change in thename and/or address of a manufacturer/importer of the | 20/12/2013 | n/a |                                                                                                    |

<div style=\"page-break-after: always\"></div>

|           | (excludingmanufacturerforbatchrelease)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |            |            |      |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|-----------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IG/0375/G | This was an application for a group of variations. A.7-Administrativechange-Deletion of manufacturing sites A.7-Administrativechange-Deletion of manufacturingsites A.5.b-Administrative change-Change in the name and/oraddressofamanufacturer/importerofthe finished product, including quality control sites (excludingmanufacturerforbatchrelease)                                                                                                                                                                                                                                                                                                                                                                                                                                                       | 25/11/2013 | n/a        |      |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| WS/0455   | This was an application for a variation following a worksharingprocedure according toArticle20of CommissionRegulation(EC)No1234/2008. Updateofsection4.2oftheSmPCinordertodraw theprescriber's attentiontothepossibilityofpatients swallowingthecapsulesinsteadofinhalingthe product as further risk minimisation for the risk of \"medication error\"，following a request from the CHMPandinordertofulfilRMP 014.Theformat of theouterandimmediateouterpackagingwas updated accordingly without affecting the labelling text.Inadditionsection4.5of theSmPChasbeen updated to bring it in line with section 12 part V Risk minimisationmeasuresoftheRMPregarding therisk of less effectof\"beta-adrenergicblockers\". C.I.z - Changes (Safety/Efficacy) of Human and VeterinaryMedicinalProducts-Othervariation | 21/11/2013 | 18/09/2014 | SmPC | Following the assessment of indacaterol RMP 014 (version 7.0of theRMP),the MAH was requested by the CHMP to insert\"medication error\"as animportant identified risk in theRMPand toproposefurtherriskminimization measures.TheMAHwas alsorequestedtorevise theouter package so that the information\"Do not swallow capsules\" and \"For inhalation use only\" is emphasized e.g. by includingaredrelativelybroadboxaround thetext andby perhapschanging thefont size.Thisvariationledto an updateofsection4.2of theSmPC and theouter and immediate packaging accordingly. In addition section 4.5 of theSmPChasbeenupdatedtobringit inlinewithsection 12partVRiskminimisationmeasuresof theRMPregarding the riskof lesseffectof\"beta-adrenergicblockers\". |

<div style=\"page-break-after: always\"></div>

| IG/0369/G   | This was an applicationfor a group of variations. B.II.a.4.a - Change in coating weight of oral dosage forms or change in weight of capsule shells - Solid oralpharmaceuticalforms B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure B.II.d.2.a-Change in test procedure for the finished product - Minor changes to an approved test procedure B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure B.II.d.2.a - Change in test procedure for the finished product-Minor changesto an approved test procedure B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test   | 20/11/2013   | n/a        |                       |                                                                                                                                                                                                                                                                                                                                                                                                      |
|-------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|-----------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| PSUV/0022   | Periodic Safety Update                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 | 27/06/2013   | 26/08/2013 | SmPC, Annex II and PL | PleaserefertoOnbrezBreezhaler-H-C-1114-PSU-8EPAR Scientific conclusions and grounds recommending the variationtothetermsofthemarketingauthorisation. InadditiontheMAH hastakentheopportunity toinclude thecontactdetailsof theCroatianlocalrepresentativeand toupdatethecontactdetailsoftheMalteselocal representative. Furthermore, Annex II is being brought in line with the latest QRD template. |

<div style=\"page-break-after: always\"></div>

|           | This was an applicationfor a groupofvariations. B.II.b.1.b-Replacement or addition of a manufacturing site for the FP - Primary packaging site B.II.b.2.a - Change to batch release arrangements andqualitycontroltestingof theFP-Replacement or addition of a site where batch control/testing takes place                                                                                                                                                                                                                        | 15/08/2013   | n/a   | IG/0336/G                         |
|-----------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|-------|-----------------------------------|
| IB/0019/G | This was an application for a group of variations. B.II.e.7.z. - Change in supplier of packaging components or devices (when mentioned in the dossier)-Other variation B.II.e.7.b - Change in supplier of packaging components ordevices(whenmentioned in the dossier)-Replacement or addition of a supplier B.II.e.7.a - Change in supplier of packaging components or devices (when mentioned in the dossier) - Deletion of a supplier B.II.e.7.a - Change in supplier of packaging components or devices (when mentioned in the | 17/07/2013   | n/a   | dossier) - Deletion of a supplier |
| IB/0020   | B.II.b.3.z-Change in the manufacturing process of thefinishedproduct-Othervariation                                                                                                                                                                                                                                                                                                                                                                                                                                                | 02/07/2013   | n/a   |                                   |
|           | This was an application for a group of variations. B.III.1.b.2-Submission of a new or updated Ph.Eur. TSECertificateof suitability-New certificatefora                                                                                                                                                                                                                                                                                                                                                                             | 24/06/2013   | n/a   | IG/0315/G                         |

<div style=\"page-break-after: always\"></div>

|           | startingmaterial/reagent/intermediate/orexcipient from a newor an already approved manufacturer B.III.1.b.3-Submission of a new or updated Ph.Eur. TSECertificateofsuitability-Updatedcertificate from an already approved manufacturer                                                                                                                           |            |            |                                  |                                                                                                                                                                                                                                                                                                                                                    |
|-----------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IG/0248   | C.I.z-Changes(Safety/Efficacy)of Human and VeterinaryMedicinalProducts-Othervariation                                                                                                                                                                                                                                                                             | 17/12/2012 | n/a        |                                  |                                                                                                                                                                                                                                                                                                                                                    |
| IG/0209/G | Thiswasanapplicationforagroupofvariations. C.I.9.b-Changes to anexistingpharmacovigilance system as described in the DDPS - Change in the contactdetailsoftheQPPV C.I.9.h - Changes to an existing pharmacovigilance system as described in the DDPS - Other change(s) to the DDPS that does not impact on the operation of the pharmacovigilance system          | 17/08/2012 | n/a        |                                  |                                                                                                                                                                                                                                                                                                                                                    |
| IG/0204   | B.II.a.1.a - Change or addition of imprints, bossing orothermarkingsincludingreplacement,oraddition of inks usedfor product marking-Changes in imprints, bossing or other markings                                                                                                                                                                                | 08/08/2012 | n/a        |                                  |                                                                                                                                                                                                                                                                                                                                                    |
| II/0014   | UponrequestfromtheCHMPfollowingthe assessmentof thePSUR,the list and frequencies of adversereactionsintheSmPCsection4.8havebeen updated based on additional data obtained post- marketing. A warning about hypersensitivity reactionshasbeen addedtoSmPCsection4.4.In addition, two pictures illustrating the use of the inhalerdevicehavebeenupdatedintheSmPCand | 21/06/2012 | 26/07/2012 | SmPC, Annex II, Labelling and PL | Basedonreviewofpooledsafetydatafrom11phaseIII studies with treatment duration of 12 weeks or longer, including4,746patientsexposedtoindacaterolupto600 microgram once-daily,thelist andfrequenciesofadverse reactionsin theSmPChasbeenrevised.Forthenewly included hypersensitivity reactions, a corresponding warninghasbeen included in theSmPC. |

<div style=\"page-break-after: always\"></div>

|           | PL. Also the SmPC, Annex II, labelling and PL have beenupdatedtothelatestQRDtemplate. C.I.4-Variations related to significant modifications of the SPC due in particular to new quality, pre- clinical, clinical or pharmacovigilance data                                                                                                                                                                                                                                                                                 |            |     |                                       |
|-----------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|---------------------------------------|
| IG/0194/G | Thiswas an applicationfor a group of variations. B.I.a.1.f -Change in the manufacturer of AS or of a startingmaterial/reagent/intermediateforAS- Changestoqualitycontroltestingarrangementsfor theAS-replacementoradditionofasitewhere batch control/testing takes place B.I.b.1.b - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Tightening of specification limits B.1.b.2.a-Change in test procedure forAS or starting material/reagent/intermediate - Minor | 12/07/2012 | n/a | changes to an approved test procedure |
|           | This was an applicationfor a group of variations. C.I.9.e-Changes to an existing pharmacovigilance system as described in the DDPS - Changes in the majorcontractual arrangementswithotherpersons or organisations involved in the fulfilment of pharmacovigilanceobligations anddescribedinthe DD C.I.9.h-Changes to anexistingpharmacovigilance system as described in the DDPS - Other change(s)                                                                                                                        | 22/02/2012 | n/a | IG/0148/G                             |

<div style=\"page-break-after: always\"></div>

|           | totheDDPSthatdoesnotimpactontheoperationof the pharmacovigilance system                                                                                                                                                                                                                                                                                                                                                                      |            |     |                              |
|-----------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|------------------------------|
| IG/0139/G | This was an application for a group of variations. A.5.b - Administrative change - Change in the name and/oraddressof amanufacturerof thefinished product, including quality control sites (excluding manufacturer for batch release) A.7-Administrativechange-Deletion of manufacturing sites A.5.b-Administrative change -Change in the name and/oraddressofamanufacturerofthefinished product, including quality control sites (excluding | 16/12/2011 | n/a | manufacturerforbatchrelease) |
| IG/0113/G | This was an application for a group of variations. B.III.1.b.3-Submission of a new or updated Ph.Eur. TSE Certificate of suitability - Updated certificate from an already approved manufacturer B.III.1.b.3 -Submission of a new or updated Ph.Eur. TSE Certificate of suitability-Updatedcertificate from an already approved manufacturer                                                                                                 | 11/11/2011 | n/a |                              |
|           | This was an application for a group of variations. C.I.9.e - Changes to an existing pharmacovigilance system as described in the DDPS - Changes in the major contractual arrangements with other persons ororganisationsinvolvedinthefulfilmentof pharmacovigilanceobligationsanddescribedinthe                                                                                                                                              | 11/07/2011 | n/a | IG/0088/G                    |

<div style=\"page-break-after: always\"></div>

<!-- image -->

|           | DD C.I.9.h - Changes to an existing pharmacovigilance system as described in the DDPS - Other change(s) totheDDPSthatdoesnotimpacton theoperationof the pharmacovigilance system                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |            |     |    |                                                                              |
|-----------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|----|------------------------------------------------------------------------------|
| N/0006    | Minorchangeinlabellingorpackageleafletnot connected with the SPC (Art.61.3 Notification)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    | 31/05/2011 | n/a | PL | Updateof thelocalrepresentativescontactdetailsin Cyprus, Poland and Romania. |
| IG/0032/G | Thiswasanapplicationforagroupofvariations. ToupdatetheDetailedDescriptionofthe Pharmacovigilance System (DDPS) to version 9.0, to include: - a change in the deputy of the Qualified Person for Pharmacovigilance (QPPV); - a change in the major contractual arrangements. - administrative changes not impacting the operation of the pharmacovigilance system. AnnexII.Bhasalsobeenupdatedwith thelatest wording as per October 2010 CHMP procedural announcement. C.I.9.c-Changestoan existingpharmacovigilance system as described in the DDPS - Change of the back-up procedure of the QPPV C.I.9.e - Changes to an existing pharmacovigilance system as described in the DDPS - Changes in the majorcontractual arrangementswithotherpersons or organisationsinvolvedinthefulfilmentof pharmacovigilanceobligationsanddescribedinthe | 21/12/2010 | n/a |    |                                                                              |

<div style=\"page-break-after: always\"></div>

|           | C.I.9.h - Changes to an existing pharmacovigilance system as described in the DDPS - Other change(s) totheDDPSthatdoesnotimpacton theoperationof the pharmacovigilance system                                                                                                                                                                                                                                                                                                                                                                                                                   |            |            |                   |
|-----------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-------------------|
| IB/0005   | C.I.3.a - Implementation of change(s) requested following the assessment of an USR, class labelling, a PSUR,RMP,FUM/SO,datasubmittedunderA45/46, or amendmentstoreflect aCoreSPC-Changes with NOnewadditionaldata aresubmitted by theMAH                                                                                                                                                                                                                                                                                                                                                        | 16/12/2010 | n/a        | SmPC and Annex II |
| IG/0025/G | Thiswasanapplicationforagroupofvariations. B.III.1.b.2 - Submission of a new or updated Ph.Eur. TSE Certificate of suitability -New certificate for a startingmaterial/reagent/intermediate/orexcipient fromaneworanalreadyapprovedmanufacturer B.III.1.b.2-Submission of a new or updated Ph.Eur. TSECertificate ofsuitability-Newcertificatefora starting material/reagent/intermediate/or excipient from a new or an already approved manufacturer B.III.1.b.3 -Submission of a new or updated Ph.Eur. TSECertificate ofsuitability-Updatedcertificate from an already approved manufacturer | 20/10/2010 | n/a        |                   |
| WS/0024   | This was an application for a variation following a worksharing procedure according to Article 20 of CommissionRegulation(EC)No1234/2008. B.I.b.2.e-Change in test procedure forAS or startingmaterial/reagent/intermediate-Other changes to a test procedure (including replacement                                                                                                                                                                                                                                                                                                            | 23/09/2010 | 23/09/2010 |                   |

<div style=\"page-break-after: always\"></div>

|         | or addition) for the AS or a starting material/intermediate                                                                                                                                                                                                                 |            |            |          |                                                                                                                                                                                                                                                                                                                                           |
|---------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IA/0004 | A.6 - Administrative change - Change in ATC Code/ATC VetCode                                                                                                                                                                                                                | 16/06/2010 | n/a        | SmPC     |                                                                                                                                                                                                                                                                                                                                           |
| I1/0001 | Updateof theDetailedDescriptionofthe Pharmacovigilance system (DDPS). Changes to QPPV Update of DDPS(Pharmacovigilance)                                                                                                                                                     | 18/02/2010 | 26/03/2010 | Annex II | WiththisvariationtheMAHsubmittedanewversionof the DDPS(core version 8.0 and product specificversion5.0)in accordancewiththecurrentPharmacovigilanceguideline. AfterassessingthedocumentationtheCHMPconcluded thatthesubmittedDDPScontainedallrequiredelements. Consequently,AnnexIIhasbeenupdatedwiththenew versionnumberoftheagreedDDPS. |
| IB/0003 | Toextendfrom18monthsto24monthstheshelf lifeof thefinishedproduct IB_42_a_01_Change in shelf-life of finished product - as packaged for sale                                                                                                                                 | 26/01/2010 | n/a        | SmPC     |                                                                                                                                                                                                                                                                                                                                           |
| IA/0002 | To addKonapharmaAG,ImWannenboden as an additionnalmanufacturingsiteforprimaryand secondarypackaging activities IA_o7_a_Replacement/add.ofmanufacturingsite: Secondary packaging site IA_07_b_01_Replacement/add.of manufacturing site: Primary packaging site - Solid forms | 21/12/2009 | n/a        |          |                                                                                                                                                                                                                                                                                                                                           |